EW - Edwards Lifesciences Corporation
| Previous Close | 231.27 |
| Open | 232.14 |
| Bid | 230.01 x 800 |
| Ask | 229.77 x 800 |
| Day's Range | 229.10 - 234.05 |
| 52 Week Range | 163.08 - 247.64 |
| Volume | 1,595,887 |
| Avg. Volume | 1,192,664 |
| Market Cap | 48.065B |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | 63.28 |
| EPS (TTM) | N/A |
| Earnings Date | Jan 29, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 250.74 |
- Zacks
Can Critical Care Aid Edwards Lifesciences (EW) Q4 Earnings?
Robust customer adoption of the HemoSphere all-in-one monitoring platform is likely to have driven Edwards Lifesciences' (EW) Q4 revenues.
- Investor's Business Daily
Leading Medtech Stock Hammered On Potential Slowdown In Heart Devices
Edwards Lifesciences stock tumbled Thursday after an analyst suggested sales of the company's heart-valve replacements, using a technique called TAVR, are experiencing a slowdown.
- GuruFocus.com
US Stocks Fall on Thursday
Texas Instruments shares tumble despite strong fourth-quarter results Continue reading...
- Zacks
Edwards Lifesciences (EW) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Edwards Lifesciences (EW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Simply Wall St.
Should We Be Delighted With Edwards Lifesciences Corporation's (NYSE:EW) ROE Of 20%?
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...
- Zacks
Here's Why You Should Retain Edwards Lifesciences Stock Now
Investors can hold on to Edwards Lifesciences (EW) in their portfolio for now, thanks to solid prospects.
- PR Newswire
Edwards Lifesciences To Host Earnings Conference Call On January 30, 2020
Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, plans to announce its operating results for the quarter ended December 31, 2019 after the market closes on Thursday, January 30, 2020, and will host a conference call at 5:00 p.m. ET that day to discuss those results.
- Zacks
Edwards Lifesciences (EW) Stock Sinks As Market Gains: What You Should Know
Edwards Lifesciences (EW) closed the most recent trading day at $231.46, moving -0.67% from the previous trading session.
- Investor's Business Daily
Stocks To Watch: Life Sciences Leader Repligen Tests New Buy With 84% Growth
Boosted by average EPS growth of 84% over the last three quarters, life sciences leader and biologic drugmaker Repligen is now testing a new buy point.
- PR Newswire
Edwards Lifesciences To Present At The 38th Annual J.P. Morgan Healthcare Conference
Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, is scheduled to present at the J.P. Morgan Healthcare Conference at the Westin St. Francis in San Francisco on Monday, January 13, 2020.
- Investopedia
Top Health Care Stocks for January 2020
These are the health care stocks with the best value, fastest growth, and most momentum for January.
- Simply Wall St.
Is Edwards Lifesciences Corporation (NYSE:EW) Excessively Paying Its CEO?
In 2000 Mike Mussallem was appointed CEO of Edwards Lifesciences Corporation (NYSE:EW). This analysis aims first to...
- Zacks
Edwards Lifesciences (EW) Stock Moves -0.5%: What You Should Know
In the latest trading session, Edwards Lifesciences (EW) closed at $234.61, marking a -0.5% move from the previous day.
- Zacks
Edwards (EW) Rides on Innovation Despite Regulatory Issues
Edwards Lifesciences' (EW) HemoSphere all-in-one monitoring platform is gaining momentum on the back of a strong rollout that sees a full-market launch.
- Insider Monkey
How Did Edwards Lifesciences Corporation (EW) Perform In Comparison to Hedge Fund Favorites in 2019?
Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged in 2019. Among them, Facebook and Microsoft ranked among the top 3 picks and these stocks gained 57%. Our research shows that most of the stocks that smart money likes historically generate strong risk-adjusted returns. That's why we weren't […]
- Zacks
Top Stock Picks for the Week of Dec 23, 2019
Tracey Ryniec takes a look at two Zacks Rank 1 (Strong Buy) stocks.
- Zacks
Zacks Market Edge Highlights: Edwards Lifesciences, Sony, Alibaba, State Street and Exxon
Zacks Market Edge Highlights: Edwards Lifesciences, Sony, Alibaba, State Street and Exxon
- Investor's Business Daily
Dow Jones Futures: Will Star Wars Force Disney Lower? Five Stocks Near Buy Points
Dow futures: Will a not-so-forceful Star Wars lift or sink Disney stock? Also, Applied Materials, KLA, Inphi, Keysight Technologies and Edwards Lifesciences have new buy points.
- Zacks
The Zacks Analyst Blog Highlights: Uber, AES, CIRCOR International, Edwards Lifesciences and Zynerba Pharmaceuticals
The Zacks Analyst Blog Highlights: Uber, AES, CIRCOR International, Edwards Lifesciences and Zynerba Pharmaceuticals
- Zacks
Investing Outlook for 2020: Recession or Not?
Some stock market bears have been waiting for a US recession for four years. Is 2020 the year they will finally be right or will they have to throw in the towel and join the bull's party?
- Zacks
Uber Is Formally into the Staffing Business
Uber Works makes Uber more like the technology platform it claims to be and less the ride-hailing service that we recognize it as.
- Zacks
Edwards Lifesciences (EW) Upgraded to Strong Buy: Here's Why
Edwards Lifesciences (EW) has been upgraded to a Zacks Rank 1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- Zacks
Edwards Lifesciences (EW) Dips More Than Broader Markets: What You Should Know
Edwards Lifesciences (EW) closed at $235.63 in the latest trading session, marking a -0.96% move from the prior day.
